Conduct of Initial Screens. Promptly following receipt of -------------------------- the Pilot Extracts, Galileo did (i) test such Pilot Extracts for activity to ensure that Assays are optimally configured for screening and (ii) begin to evaluate the Pilot Extracts for assay interference. In the event that such interference is identified, Galileo shall attempt to modify its Assays as necessary in order to enable successful completion. Galileo shall promptly notify the Committee of any modification so implemented. As of the Effective Date, the Pilot Extract evaluation has not been completed, but sufficient analysis has been conducted to ensure that there is adequate compatibility between the Assays and Pilot Extracts to conclude that the Program can be successfully pursued and should proceed. Upon the completion of the __________________________ * This portion of the Exhibit has been omitted pursuant to a Request for Confidential Treatment under Rule 406 of the Securities Act of 1933, as amended. The complete Exhibit, including the portions for wich confidential treatment has been requested, has been filed separately with the Securities and Exchange Commission.
Appears in 2 contracts
Sources: Research Collaboration and License Agreement (Phytera Inc), Research Collaboration and License Agreement (Phytera Inc)